✦ LIBER ✦

CpG hypermethylation of the promoter region inactivates the estrogen receptor-β gene in patients with prostate carcinoma

✍ Scribed by Dana Nojima; Long-Cheng Li; Abhipsa Dharia; Geetha Perinchery; Leopoldo Ribeiro-Filho; Tien-Sze B. Yen; Rajvir Dahiya

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 561 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011015)92:8<2076::aid-cncr1548>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inactivation of the human androgen recep

Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer

✍ Masahiro Sasaki; Bong R. Oh; Abhipsa Dharia; Seiichiro Fujimoto; Rajvir Dahiya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 3 views

Ethnic group-related differences in CpG

✍ Hideki Enokida; Hiroaki Shiina; Shinji Urakami; Mikio Igawa; Tatsuya Ogishima; D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 451 KB 👁 2 views

## Abstract The incidence and mortality of prostate cancer (PC) is approximately 2‐fold higher among African‐Americans as compared to Caucasians and very low in Asian. We hypothesize that inactivation of __GSTP1__ genes through CpG methylation plays a role in the pathogenesis of PC, and its ability

Androgen, estrogen, and progesterone rec

Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate

✍ Dr. Vijay L. Kumar; Surender N. Wadhwa; Vijay Kumar; Ahmad Farooq 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Hypermethylation of the tumor necrosis f

Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor κB sites in prostatic carcinoma

✍ Simon Santourlidis; Ulrich Warskulat; Andrea R. Florl; Simone Maas; Thomas Pulte 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

DNA hypermethylation of CpG-rich promoter sequences is associated with tumor suppressor gene inactivation in many human cancers, notably in carcinoma of the prostate and the urinary bladder. Recently, the mouse homologue of the tumor necrosis factor receptor superfamily 6 (TNFRSF6) gene was reported